Proven lower-cost options could save consumer $1,200 a year or more
Five of the 10 drugs in a class called ACE Inhibitors –used to treat people with high blood pressure, heart disease and diabetes – have been chosen as Consumer Reports Best Buy Drugs, with potential annual savings of $1,200 a year over higher-priced medications. Read more (PDF).